ZSCAN30
Zinc finger and SCAN domain-containing protein 30
Also known as: ZNF397OS, ZNF917, ZSC30_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q86W11
- Gene
- ZSCAN30
- Ensembl
- ENSG00000186814
- Chromosome
- 18
- Canonical length
- 494 aa
- Protein class
- Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm,Cytosol
OverviewNCBI Gene
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be located in nucleus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
494 residues, UniProt reviewed canonical sequence.
>Q86W11|ZSCAN30
1 MSGEATVLAY HAPEEQEGLL VVKVEEENYV LDQDFGLQEN PWSQEVFRQK FRQFSYSDST
61 GPREALSRLR ELCCQWLRPE VHSKEQILEL LMLEQFLAIL PEELQAWLRE HRPENGEEAV
121 TMLEELEKEL EEPRQQDTTH GQEMFWQEMT STGALKSLSL NSPVQPLENQ CKTETQESQA
181 FQERDGRMVA GKVLMAKQEI VECVASAAMI SPGKLPGETH SQRIAEEALG GLDNSKKQKG
241 NAAGNKISQL PSQDRHFSLA TFNRRIPTEH SVLESHESEG SFSMNSNDIT QQSVDTREKL
301 YECFDCGKAF CQSSKLIRHQ RIHTGERPYA CKECGKAFSL SSDLVRHQRI HSGEKPYECC
361 ECGKAFRGSS ELIRHRRIHT GEKPYECGEC GKAFSRSSAL IQHKKIHTGD KSYECIACGK
421 AFGRSSILIE HQRIHTGEKP YECNECGKSF NQSSALTQHQ RIHTGEKPYE CSECRKTFRH
481 RSGLMQHQRT HTRVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ZSCAN30 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.49
- Highest tissue expression
- 25 nTPM
Expression across tissuesHPA
Tissue
- retina: 25 nTPM
- cerebellum: 25 nTPM
- heart muscle: 17 nTPM
- pituitary gland: 16 nTPM
- skeletal muscle: 16 nTPM
- thyroid gland: 14 nTPM
Single-cell type
- myonuclei: 130 nCPM
- cardiomyocytes: 80 nCPM
- oligodendrocytes: 61 nCPM
- lactotrophs: 57 nCPM
- choroid plexus epithelial cells: 54 nCPM
- somatotrophs: 51 nCPM
Immune cell
- naive B-cell: 3.3 nTPM
- naive CD8 T-cell: 2.6 nTPM
- plasmacytoid DC: 2.6 nTPM
- memory B-cell: 2.5 nTPM
- eosinophil: 2.3 nTPM
- naive CD4 T-cell: 2.3 nTPM
Brain region
- white matter: 86 nTPM
- cerebellum: 84 nTPM
- hypothalamus: 66 nTPM
- cerebral cortex: 64 nTPM
- basal ganglia: 63 nTPM
- thalamus: 63 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.43
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.07
- DepMap mean gene effect
- -0.05
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- DNA-binding transcription factor activity, RNA polymerase II-specific
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ZSCAN30 as an antibody target. Whether an autoantibody or antibody against ZSCAN30 could matter depends on whether native ZSCAN30 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ZSCAN30 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ZSCAN30 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...